drugset / Trial / NCT00716443

Evaluate Efficacy, Safety & Subject Satisfaction of Pain Management With Pliaglis® Cream for Dermal Filler Injections

NCT00716443

Phase 4 Terminated 51 enrolled Galderma R&D
RandomizedSingle-groupSingle-blindTreatment

Summary

Pliaglis® Cream versus compounded topical anesthetic for pain management during Restylane® injections for the correction of nasolabial folds.

Timeline

Start
2008-07
Primary completion
2008-09
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Benzocaine Small molecule 20 % Topical
Comparator Lidocaine Other / unclassified 6 % Topical
Comparator Lidocaine Other / unclassified 7 % Topical
Comparator tetracaine Other / unclassified 4 % Topical
Comparator tetracaine Other / unclassified 7 % Topical

Indications

No indication recorded.